Medicare GLP-1 Bridge program opens for certain Part D patients with $50 monthly copay

A temporary Medicare bridge program for GLP-1 weight-loss drugs is now live. The program offers coverage for eligible Medicare Part D beneficiaries at a $50 monthly copay. This is a stopgap measure initiated by the Trump administration, distinct from the broader coverage questions facing commercial insurers. For practices, this changes coverage verification for a subset of Medicare patients seeking GLP-1s for weight management. Confirm patient eligibility and plan participation before prescribing, as this is a specific, limited program with defined parameters.